Notably, we found similar results with the serum samples of breast cancer patients, which illustrated as high circulatory level of AnxA2 in serum samples of TNBC patients compared to ER+, HER2+, and normal healthy females. This evidence concerns the gene ANXA2 and breast carcinoma.